- Home
- JRSH vs LPCN Comparison
JRSH vs LPCN Comparison
Compare JRSH & LPCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JRSH
- LPCN
- Stock Information
- Founded
- JRSH 2016
- LPCN 1997
- Country
- JRSH United States
- LPCN United States
- Employees
- JRSH N/A
- LPCN N/A
- Industry
- JRSH Apparel
- LPCN Biotechnology: Pharmaceutical Preparations
- Sector
- JRSH Consumer Discretionary
- LPCN Health Care
- Exchange
- JRSH Nasdaq
- LPCN Nasdaq
- Market Cap
- JRSH 41.8M
- LPCN 36.8M
- IPO Year
- JRSH 2018
- LPCN N/A
- Fundamental
- Price
- JRSH $3.33
- LPCN $4.98
- Analyst Decision
- JRSH
- LPCN Strong Buy
- Analyst Count
- JRSH 0
- LPCN 1
- Target Price
- JRSH N/A
- LPCN $10.00
- AVG Volume (30 Days)
- JRSH 21.6K
- LPCN 30.1K
- Earning Date
- JRSH 02-06-2025
- LPCN 11-07-2024
- Dividend Yield
- JRSH 5.78%
- LPCN N/A
- EPS Growth
- JRSH N/A
- LPCN N/A
- EPS
- JRSH N/A
- LPCN N/A
- Revenue
- JRSH $130,270,418.00
- LPCN $7,922,926.00
- Revenue This Year
- JRSH $34.21
- LPCN N/A
- Revenue Next Year
- JRSH $10.31
- LPCN N/A
- P/E Ratio
- JRSH N/A
- LPCN N/A
- Revenue Growth
- JRSH N/A
- LPCN N/A
- 52 Week Low
- JRSH $2.68
- LPCN $2.44
- 52 Week High
- JRSH $3.59
- LPCN $11.79
- Technical
- Relative Strength Index (RSI)
- JRSH 49.23
- LPCN 50.88
- Support Level
- JRSH $3.40
- LPCN $4.70
- Resistance Level
- JRSH $3.59
- LPCN $5.28
- Average True Range (ATR)
- JRSH 0.11
- LPCN 0.32
- MACD
- JRSH -0.01
- LPCN 0.04
- Stochastic Oscillator
- JRSH 16.39
- LPCN 69.53
About JRSH Jerash Holdings (US) Inc.
Jerash Holdings (US) Inc along with its subsidiaries is a manufacturer and exporter of customized, ready-made sport and outerwear from knitted fabric from its production facilities in Jordan. The company manufactures for retailers namely Walmart, Costco, Sears, Hanes, Columbia, Land's End, VF Corporation, and Philip-Van Heusen which owns brands such as The North Face, Nautica, Timberland, Wrangler, Lee, Jansport, Calvin Klein, Tommy Hilfiger, IZOD, Speedo etc. It derives its revenue from the manufacturing and sales of outerwear in the United States. The company's product offering consists of jackets, polo shirts, crew neck shirts, pants, and shorts made from knitted fabric. Geographically, the company generates maximum revenue from the United States.
About LPCN Lipocine Inc.
Lipocine Inc is a clinical-stage biopharmaceutical company. It is focused on oral drug delivery technology for the development of pharmaceutical products focusing on metabolic and endocrine disorders. The company's product TLANDO is an oral testosterone replacement therapy ("TRT"). It also has other products in the pipeline such as LPCN 1144, LPCN 1148, and LPCN 1107. The Company has single reportable segment being, research and development for the delivery of drugs using its proprietary delivery technology.